Here is our next release. Things are looking better.
-----------------------------
NEWS RELEASE
Date: July 15, 1998 Trading Symbol OTC BB : RYBO
New President Appointed
Mr. Ken Pappas, Chairman of the Board for Royce Biomedical Inc., is pleased
to announce that Mr. Gregory Sharpe has accepted the position as President
of the company. Mr. Sharpe will officially assume his duties and
responsibilities on July 15, 1998.
Mr. Sharpe brings to Royce Biomedical substantial knowledge of business
systems and government process in many foreign countries. He has spent over
10 years in the international marketplace with experience in the creation of
representative offices and joint ventures abroad. He brings strong
communication skills, product development knowledge, and international
marketing experience to the company.
Prior to accepting this appointment, Mr. Sharpe spent two months conducting
his due diligence on the company. He states, "I am very impressed with the
simplicity and accuracy of Royce's technology. An analysis of the potential
market for Royce's product line was also extremely positive. I am convinced
that with dedicated management and leadership these products will sell."
Royce Biomedical Inc., (RYBO-OTC Bulletin Board) is a state of the art
developer, manufacturer and marketer of rapid result, medical diagnostic
test kits with offices in Beijing, China and corporate Head Offices in
Vancouver, British Columbia, Canada. Royce is maintaining its objectives for
rapid and consistent growth through the implementation of a progressive
sales and marketing program.
"signed"
Ken Pappas
Chairman of the Board |
